271 related articles for article (PubMed ID: 22764249)
21. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
[TBL] [Abstract][Full Text] [Related]
22. Methylphenidate affects striatal dopamine differently in an animal model for attention-deficit/hyperactivity disorder--the spontaneously hypertensive rat.
Russell VA; de Villiers AS; Sagvolden T; Lamm MC; Taljaard JJ
Brain Res Bull; 2000 Sep; 53(2):187-92. PubMed ID: 11044595
[TBL] [Abstract][Full Text] [Related]
23. Increased glutamate-stimulated release of dopamine in substantia nigra of a rat model for attention-deficit/hyperactivity disorder--lack of effect of methylphenidate.
Warton FL; Howells FM; Russell VA
Metab Brain Dis; 2009 Dec; 24(4):599-613. PubMed ID: 19821016
[TBL] [Abstract][Full Text] [Related]
24. GC-TOF-MS-Based Metabolomic Analysis and Evaluation of the Effects of HX106, a Nutraceutical, on ADHD-Like Symptoms in Prenatal Alcohol Exposed Mice.
Ju IG; Lee MY; Jeon SH; Huh E; Kim JH; Lee JK; Lee CH; Oh MS
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33023237
[TBL] [Abstract][Full Text] [Related]
25. Long-term relationship between methylphenidate and tobacco consumption and nicotine craving in adults with ADHD in a prospective cohort study.
Bron TI; Bijlenga D; Kasander MV; Spuijbroek AT; Beekman AT; Kooij JJ
Eur Neuropsychopharmacol; 2013 Jun; 23(6):542-54. PubMed ID: 22809706
[TBL] [Abstract][Full Text] [Related]
26. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
Ruocco LA; Carnevale UA; Treno C; Sadile AG; Melisi D; Arra C; Ibba M; Schirru C; Carboni E
Behav Brain Res; 2010 Jun; 210(1):99-106. PubMed ID: 20156489
[TBL] [Abstract][Full Text] [Related]
27. Paternal nicotine exposure induces hyperactivity in next-generation via down-regulating the expression of DAT.
Zhang M; Zhang D; Dai J; Cao Y; Xu W; He G; Wang Z; Wang L; Li R; Qiao Z
Toxicology; 2020 Feb; 431():152367. PubMed ID: 31945395
[TBL] [Abstract][Full Text] [Related]
28. Prenatal exposure to nicotine impairs performance of the 5-choice serial reaction time task in adult rats.
Schneider T; Ilott N; Brolese G; Bizarro L; Asherson PJ; Stolerman IP
Neuropsychopharmacology; 2011 Apr; 36(5):1114-25. PubMed ID: 21289608
[TBL] [Abstract][Full Text] [Related]
29. Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism.
Hara Y; Ago Y; Taruta A; Katashiba K; Hasebe S; Takano E; Onaka Y; Hashimoto H; Matsuda T; Takuma K
Autism Res; 2016 Sep; 9(9):926-39. PubMed ID: 26714434
[TBL] [Abstract][Full Text] [Related]
30. Maternal smoking during pregnancy and physiological anxiety in children with attention deficit hyperactivity disorder.
Zambrano-Sánchez E; Martínez-Cortés J; Poblano A; Dehesa-Moreno M; Vázquez-Urbano F; Del Río-Carlos Y
Appl Neuropsychol Child; 2021 Jan; 10(1):82-89. PubMed ID: 31269807
[TBL] [Abstract][Full Text] [Related]
31. Atomoxetine Reestablishes Long Term Potentiation in a Mouse Model of Attention Deficit/Hyperactivity Disorder.
Piña R; Rozas C; Contreras D; Hardy P; Ugarte G; Zeise ML; Rojas P; Morales B
Neuroscience; 2020 Jul; 439():268-274. PubMed ID: 31809728
[TBL] [Abstract][Full Text] [Related]
32. Long-term consequences of maternal smoking and developmental chronic nicotine exposure.
Winzer-Serhan UH
Front Biosci; 2008 Jan; 13():636-49. PubMed ID: 17981576
[TBL] [Abstract][Full Text] [Related]
33. Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.
Schrantee A; Tamminga HG; Bouziane C; Bottelier MA; Bron EE; Mutsaerts HJ; Zwinderman AH; Groote IR; Rombouts SA; Lindauer RJ; Klein S; Niessen WJ; Opmeer BC; Boer F; Lucassen PJ; Andersen SL; Geurts HM; Reneman L
JAMA Psychiatry; 2016 Sep; 73(9):955-62. PubMed ID: 27487479
[TBL] [Abstract][Full Text] [Related]
34. [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].
Emond V; Joyal C; Poissant H
Encephale; 2009 Apr; 35(2):107-14. PubMed ID: 19393378
[TBL] [Abstract][Full Text] [Related]
35. Reward-enhancing effect of methylphenidate is abolished in dopamine transporter knockout mice: A model of attention-deficit/hyperactivity disorder.
Ide S; Ikekubo Y; Hua J; Takamatsu Y; Uhl GR; Sora I; Ikeda K
Neuropsychopharmacol Rep; 2018 Sep; 38(3):149-153. PubMed ID: 30175528
[TBL] [Abstract][Full Text] [Related]
36. Hyperactivity and memory/learning deficits evoked by developmental exposure to nicotine and/or ethanol are mitigated by cAMP and cGMP signaling cascades activation.
Abreu-Villaça Y; Carvalho-Graça AC; Skinner G; Lotufo BM; Duarte-Pinheiro VHS; Ribeiro-Carvalho A; Manhães AC; Filgueiras CC
Neurotoxicology; 2018 May; 66():150-159. PubMed ID: 29653137
[TBL] [Abstract][Full Text] [Related]
37. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
Volkow ND; Wang GJ; Newcorn J; Telang F; Solanto MV; Fowler JS; Logan J; Ma Y; Schulz K; Pradhan K; Wong C; Swanson JM
Arch Gen Psychiatry; 2007 Aug; 64(8):932-40. PubMed ID: 17679638
[TBL] [Abstract][Full Text] [Related]
38. Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: a pilot randomized placebo-controlled trial.
Hurt RD; Ebbert JO; Croghan IT; Schroeder DR; Sood A; Hays JT
J Negat Results Biomed; 2011 Jan; 10():1. PubMed ID: 21276244
[TBL] [Abstract][Full Text] [Related]
39. Prenatal exposure to cigarette smoke or alcohol and cerebellum volume in attention-deficit/hyperactivity disorder and typical development.
de Zeeuw P; Zwart F; Schrama R; van Engeland H; Durston S
Transl Psychiatry; 2012 Mar; 2(3):e84. PubMed ID: 22832850
[TBL] [Abstract][Full Text] [Related]
40. Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination.
Smith A; Cubillo A; Barrett N; Giampietro V; Simmons A; Brammer M; Rubia K
Biol Psychiatry; 2013 Oct; 74(8):615-22. PubMed ID: 23731741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
